查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1980752

2026-2034年全球植入式心臟節律管理設備市場規模、佔有率、趨勢和成長分析報告

Global Implantable Cardiac Rhythm Management Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計植入式心臟節律管理設備的市場規模將從 2025 年的 201.1 億美元成長到 2034 年的 485.9 億美元，2026 年至 2034 年的複合年成長率為 10.3%。

由於心血管疾病和心律不整的盛行率不斷上升，全球植入式心臟節律管理裝置（ICR）市場正經歷顯著成長。 ICR，包括心律調節器和植入式心臟整流去顫器（ICD），廣泛用於監測和調節異常心律。這些裝置在預防危及生命的心臟事件和提高患者存活率方面發揮著至關重要的作用。

人們對心臟健康的日益關注以及心臟植入式設備技術的進步是推動市場擴張的主要因素。現代植入式設備體積更小、效率更高，並且能夠透過無線連接進行遠端監測。這些創新使醫療專業人員能夠持續監測患者的心臟活動，並據此調整治療方案。此外，全球人口老化也顯著促進了心臟節律管理解決方案的需求成長。

展望未來，由於技術的持續創新和醫療保健投資的不斷增加，市場預計將保持持續成長。各公司正致力於開發電池續航力更長、監控功能更強大的新一代植入式設備。隨著醫療保健系統將心臟疾病的早期發現和管理置於優先地位，植入式心臟節律監測設備將在改善心血管護理方面繼續發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球植入式心臟節律管理設備市場：依裝置類型分類

  • 市場分析、洞察與預測
  • 心臟再同步治療裝置
  • 植入式心臟整流去顫器
  • 心律調節器

第5章 全球植入式心臟節律管理設備市場：依技術分類

  • 市場分析、洞察與預測
  • 雙心室
  • 雙腔體
  • 單室

第6章 全球植入式心臟節律管理設備市場：依組件分類

  • 市場分析、洞察與預測
  • 帶領
  • 脈衝發生器

第7章 全球植入式心臟節律管理設備市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 門診手術中心
  • 心臟病診所
  • 醫院

第8章：全球植入式心臟節律管理設備市場：依年齡層別分類

  • 市場分析、洞察與預測
  • 成人
  • 兒童

第9章 全球植入式心臟節律管理設備市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic Plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • MicroPort Scientific Corporation
    • LivaNova PLC
    • Koninklijke Philips NV
    • Lepu Medical Technology（Beijing）Co. Ltd
    • Johnson & Johnson（Biosense Webster/Formerly St. Jude Medical）
    • Stryker Corporation
簡介目錄
Product Code: VMR112115231

The Implantable Cardiac Rhythm Management Devices Market size is expected to reach USD 48.59 Billion in 2034 from USD 20.11 Billion (2025) growing at a CAGR of 10.3% during 2026-2034.

The Global Implantable Cardiac Rhythm Management Devices Market is witnessing strong growth due to the increasing prevalence of cardiovascular diseases and cardiac arrhythmias. Implantable cardiac rhythm management devices, including pacemakers and implantable cardioverter defibrillators (ICDs), are widely used to monitor and regulate abnormal heart rhythms. These devices play a critical role in preventing life-threatening cardiac events and improving patient survival rates.

Growing awareness about heart health and advancements in cardiac device technology are major drivers of market expansion. Modern implantable devices are becoming smaller, more efficient, and capable of remote monitoring through wireless connectivity. These innovations enable healthcare providers to continuously monitor patient heart activity and adjust treatment plans accordingly. Additionally, the aging global population is significantly contributing to the increasing demand for cardiac rhythm management solutions.

Looking ahead, the market is expected to experience sustained growth due to continuous technological innovation and rising healthcare investments. Companies are focusing on developing next-generation implantable devices with longer battery life and enhanced monitoring capabilities. As healthcare systems prioritize early detection and management of cardiac conditions, implantable cardiac rhythm management devices will continue to play a vital role in improving cardiovascular care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

  • Cardiac Resynchronization Therapy Device
  • Implantable Cardioverter Defibrillator
  • Pacemaker

By Technology

  • Biventricular
  • Dual Chamber
  • Single Chamber

By Component

  • Leads
  • Pulse Generator

By End User

  • Ambulatory Surgical Centers
  • Cardiac Specialty Clinics
  • Hospitals

By Age Group

  • Adult
  • Pediatric

COMPANIES PROFILED

  • Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE Co KG, MicroPort Scientific Corporation, LivaNova PLC, Koninklijke Philips NV, Lepu Medical Technology Beijing Co Ltd, Johnson Johnson Biosense Webster formerly St Jude Medical, Stryker Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Device Type
  • 4.2. Cardiac Resynchronization Therapy Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Implantable Cardioverter Defibrillator Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Pacemaker Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Biventricular Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Dual Chamber Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Single Chamber Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Component
  • 6.2. Leads Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pulse Generator Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cardiac Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY AGE GROUP 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Age Group
  • 8.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Device Type
    • 9.2.2 By Technology
    • 9.2.3 By Component
    • 9.2.4 By End User
    • 9.2.5 By Age Group
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Device Type
    • 9.3.2 By Technology
    • 9.3.3 By Component
    • 9.3.4 By End User
    • 9.3.5 By Age Group
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Device Type
    • 9.4.2 By Technology
    • 9.4.3 By Component
    • 9.4.4 By End User
    • 9.4.5 By Age Group
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Device Type
    • 9.5.2 By Technology
    • 9.5.3 By Component
    • 9.5.4 By End User
    • 9.5.5 By Age Group
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Device Type
    • 9.6.2 By Technology
    • 9.6.3 By Component
    • 9.6.4 By End User
    • 9.6.5 By Age Group
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Medtronic Plc
    • 11.2.2 Abbott Laboratories
    • 11.2.3 Boston Scientific Corporation
    • 11.2.4 Biotronik SE & Co. KG
    • 11.2.5 MicroPort Scientific Corporation
    • 11.2.6 LivaNova PLC
    • 11.2.7 Koninklijke Philips N.V
    • 11.2.8 Lepu Medical Technology (Beijing) Co. Ltd
    • 11.2.9 Johnson & Johnson (Biosense Webster / Formerly St. Jude Medical)
    • 11.2.10 Stryker Corporation